The aim of this audit is to ensure appropriate prescribing of antipsychotics in patients aged 65 years and over with a diagnosis of dementia. This will be achieved by measuring the degree to which prescribing of antipsychotics to patients aged 65 years and over is in line with current NICE guidance, and supporting the identification of patients where it may be appropriate to reduce or discontinue their antipsychotic prescription.
|
The resource underwent an assessment for review in September 2024. At that time, members of the All Wales Prescribing Advisory Group (AWPAG) agreed that a review of the resource was not required and that the resource will be reassessed for review in 2028. |
⇩ CEPP National Audit - Antipsychotics in Dementia 779KB (PDF) |
(December 2018, Retired June 2025)
Additional resources
⇩ CEPP National Audit - Antipsychotics in Dementia - Data collection tool 52KB (Excel) |
⇩ CEPP National Audit - Antipsychotics in Dementia - Data summary tool 255KB (Excel) |